Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.2.0.727
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenues:        
Product revenues $ 774,054 $ 1,154,569 $ 1,750,925 $ 1,867,828
Other service revenues 29,249 29,351 62,781 39,761
Development service revenues 22,438 4,984 22,438 103,846
Total revenues 825,741 1,188,904 1,836,144 2,011,435
Cost of product revenues 394,821 576,935 780,430 927,620
Research and development costs 426,931 898,423 954,443 1,716,044
Selling, general, and administrative expenses 2,187,393 $ 1,929,134 4,476,053 $ 3,729,933
Restructuring charges $ 499,184   $ 1,252,584  
Gain on sale of intellectual property       $ (4,338,601)
Operating income (loss) $ (2,682,588) $ (2,215,588) $ (5,627,366) (23,561)
Other income (expense):        
Gain (loss) on change in fair value of derivative liabilities (186,304) 875,546 (969,106) 1,359,336
Other income, net 115,522 25,993 198,209 129,379
Interest income 4,744 4,644 12,195 7,251
Interest expense (311,525) (283,695) (619,337) (435,103)
Net income (loss) $ (3,060,151) $ (1,593,100) $ (7,005,405) $ 1,037,302
Net income (loss) per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.04) $ (0.03) $ (0.12) $ 0.02
Diluted (in dollars per share) $ (0.04) $ (0.03) $ (0.12) $ 0.02
Weighted average shares outstanding:        
Basic (in shares) 74,842,841 58,919,945 59,240,848 58,817,350
Diluted (in shares) 74,842,841 58,919,945 59,240,848 60,602,643